ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

156 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q3 2023.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,144,110 shares of 27,767,902 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2,100,000 shares), BlackRock Inc. (1,979,060 shares), FARALLON CAPITAL MANAGEMENT LLC (1,875,000 shares), VANGUARD GROUP INC (1,660,520 shares), BRAIDWELL LP (1,038,310 shares), MILLENNIUM MANAGEMENT LLC (1,023,123 shares), NORTHERN TRUST CORP (959,906 shares), Krensavage Asset Management, LLC (735,103 shares), Assenagon Asset Management S.A. (631,626 shares), and MORGAN STANLEY (564,566 shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.